Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Epilepsi
Tag: Epilepsi
Saniona has started dosing in the SAN711 trial
8 October, 2024
Saniona’s CEO: “SAN2355 is a highly promising candidate for commercialization”
3 October, 2024
Saniona comments on the approval to initiate epilepsy study
19 September, 2024
She is CombiGene’s new CSO
31 May, 2024
CombiGene’s CEO comments on the patent approvals in Australia and India
20 March, 2024
Comments from Orphazyme on the investment in CombiGene
4 March, 2024
Saniona on the new epilepsy candidate SAN2355
3 January, 2024
Saniona made further progress during Q3
5 December, 2023
Saniona’s CEO: ”Selectivity is the cornerstone of future epilepsy treatments”
23 November, 2023
CombiGene’s CEO on the terminated collaboration with Spark
16 October, 2023
1
2
Page 1 of 2